DCGI suspends Serum Institute`s phase 2, 3 clinical trials of AstraZeneca`s COVID-19 vaccine

The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders.

from Zee News :India National https://ift.tt/33nbJzu

• Tweet
• Share
• Share
• Share
• Share